Targeting CD73 in the tumor microenvironment with MEDI9447

Carl M. HayMedImmune, LLC, Gaithersburg, MD, USA

Erin SultMedImmune, LLC, Gaithersburg, MD, USA

Qihui HuangMedImmune, LLC, Gaithersburg, MD, USA

Kathy MulgrewMedImmune, LLC, Gaithersburg, MD, USA

Stacy R. FuhrmannMedImmune, LLC, Gaithersburg, MD, USA

Kelly A. McGlincheyMedImmune, LLC, Gaithersburg, MD, USA

Scott A. HammondMedImmune, LLC, Gaithersburg, MD, USA

Raymond RothsteinMedImmune, LLC, Gaithersburg, MD, USA

Jonathan Rios-DoriaMedImmune, LLC, Gaithersburg, MD, USA

Edmund PoonMedimmune, LLC, MedImmune, Cambridge, UK

Nick HoloweckyjMedImmune, LLC, Gaithersburg, MD, USA

Nicholas M. DurhamMedImmune, LLC, Gaithersburg, MD, USA

Ching Ching LeowAstrazeneca, Gaithersburg, MD, USA

Gundo DiedrichMacrogenics, MacroGenics, Inc., Rockville, MD, USA

Melissa DamschroderMedImmune, LLC, Gaithersburg, MD, USA

Ronald HerbstMedImmune, LLC, Gaithersburg, MD, USA

Robert E. HollingsworthMedImmune, LLC, Gaithersburg, MD, USA

Kris F. SachsenmeierMedImmune, LLC, Gaithersburg, MD, USACorrespondence[email protected]

Your download is now in progress and you may close this window